BioIVT Webinar Will Discuss How to Manage Uncooperative Drugs in In Vitro Transporter Research

This presentation will offer practical strategies to achieve definitive results when researching unstable, sticky, or insoluble compounds.

Watson-Marlow Fluid Technology Solutions to Showcase Fluid Path Product Range at ISPE Boston

Visit stand W113 to meet WMFTS engineers and discuss single use fluid path processes at ISPE Annual Product Show

Alfa Chemistry Unveils Revitalized Strong/Weak Acid Cation Resin and Base Anion Resin Lineup

CD ComputaBio Unveils Cutting-Edge Advances in Antibody Drug Design and Development

CD ComputaBio Launches Revolutionary Antibody De Novo Design Service Pioneering Precision Medicine with AI

Genedata Collaborates with Astellas to Facilitate Regenerative Cell Therapy Product Development

Ann Graham, Founder of MIB Agents, Joins NCCN Guidelines Panel

Ann Graham, Founder and Executive Director of MIB Agents, a leading pediatric osteosarcoma nonprofit dedicated to making it better for its community of patients, caregivers, doctors, and researchers, has officially joined the National Comprehensive Cancer Network® (NCCN®) Clinical Practice Guidelines in Oncology (NCCN Guidelines®) Panel for Bone Cancer, in the role of patient advocate.

CD Formulation Demonstrates Expertise in CAR-T and CAR-NK Cell Development for Drug Delivery Systems

Daptomycin ReadyMade™ Solution to Power Up Spectrum and Microbiology Applications

Verdot expands offering with FlexiPro™ TFF system to meet growing industry demand

Leading downstream bioprocessing technology company, Verdot, announces the launch of its FlexiPro™ TFF, a multipurpose tangential flow filtration (TFF) GMP system, in response to rising industry demand for gene therapy, vaccine, and mRNA-based therapeutics.

Samsung Biologics announces expanded strategic agreement with Bristol Myers Squibb to manufacture an antibody cancer drug substance

Custom Stainless Enclosures Highlights 4Xxtreme® Double Seal Enclosures™

Invitation to learn from the best: Evening of insights and networking will honor a clinical data management stalwart

Invitation to learn from the best: Evening of insights and networking will honor a clinical data management stalwart Prof Deborah Ashby to give the 2023 Sally Hollis Memorial Lecture in Macclesfield

BRIM closes a $45.8 million rights issue early to accelerate its pipeline of regenerative peptides

BRIM Biotechnology, Inc. (“BRIM,” TPEx 6885), a clinical-stage biotechnology company focusing on developing regenerative peptides for ophthalmology and degenerative joint diseases, announced today that 22,500 shares have been issued at a premium of NT$65 (~US$2.03), raising a total of NT$1.4625 billion (~US$45.8 million). The rights issue was fully paid on 31st August 2023, four days early compared to the scheduled date of 4th September.

Torx® Software announces global drug discovery collaboration with CDD Vault®

Torx® Software Limited has launched a major international collaboration with CDD Vault, which will create a shared digital ecosystem for drug discovery data

SMi Systems secures UK patent for breakthrough single molecule imaging capabilities

SMi Systems has secured a patent from the UK Intellectual Property Office for the single-molecule imaging technologies that underpin its super-resolution multi-omic platform.

Central California Alliance for Health Selects ZeOmega’s Care Management Solution to Support Whole-Person Care

Central California Alliance for Health (CCAH), just announced they selected ZeOmega’s care management solution to support its 420,000+ Medi-Cal members, including those in the most vulnerable communities. ZeOmega’s platform will enable CCAH to pinpoint the care needs of at-risk members and champion CalAIM’s efforts to provide equitable, person-centered care across California. This partnership also reflects the increased demand for flexible and scalable technology solutions to support government-sponsored healthcare programs across the nation.

New Cell & Gene Therapy Solutions from Form Bio Analyze Billions of Potential Construct Candidates, Reducing Time-to-Clinic

Form Bio, the provider of advanced computational life sciences technology announced today capabilities for cell and gene therapy companies to rapidly model billions of potential construct candidates. With great progress to date but headwinds around safety and manufacturability, Form’s new solutions help therapy developers find the safest and highest yielding versions of their therapies.

Huateng Pharma to Attend CPHI Barcelona 2023

Huateng Pharma will be attending CPhI Worldwide, Booth 3C02, Hall 3.

Launch of high-quality (pre-clinical) enzymes suitable for pre-clinical and process development in mRNA vaccine and therapeutics

Takara Bio Europe has announced the launch of new high-quality grade mRNA production enzymes suitable for pre-clinical and process development in mRNA vaccine and therapeutic manufacturing.